• Explore /
  • Poster
  • / The Global POLAR program: Calmangafodipir used on top of modified FOLFOX6 (5-FU/FA and oxaliplatin) to prevent chemotherapy induced peripheral neuropathy (CIPN).

The Global POLAR program: Calmangafodipir used on top of modified FOLFOX6 (5-FU/FA and oxaliplatin) to prevent chemotherapy induced peripheral neuropathy (CIPN).

Abstract Poster

Authors

null

Per Pfeiffer

Department of Oncology, Odense University Hospital, Odense, Denmark

Per Pfeiffer , Camilla Qvortrup , Kei Muro , Maryam B. Lustberg , Fumiko Nagahama , Yusuke Sonehara , Marie Helene Bengtson , Malin Nittve , Christian Sonesson , Carl Stefan Carlsson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT03654729

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr TPS722)

DOI

10.1200/JCO.2019.37.4_suppl.TPS722

Abstract #

TPS722

Poster Bd #

Q7

Abstract Disclosures

Similar Posters

First Author: Maryam B. Lustberg

First Author: In Gyu Hwang

First Author: Patricio Eduardo Yanez

First Author: Jennifer Leigh Lund